These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 8411068)

  • 1. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
    J Med Genet; 1993 Sep; 30(9):737-44. PubMed ID: 8411068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
    J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.
    Nicholson LV; Johnson MA; Bushby KM; Gardner-Medwin D; Curtis A; Ginjaar IB; den Dunnen JT; Welch JL; Butler TJ; Bakker E
    J Med Genet; 1993 Sep; 30(9):728-36. PubMed ID: 8411067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.
    Anthony K; Arechavala-Gomeza V; Ricotti V; Torelli S; Feng L; Janghra N; Tasca G; Guglieri M; Barresi R; Armaroli A; Ferlini A; Bushby K; Straub V; Ricci E; Sewry C; Morgan J; Muntoni F
    JAMA Neurol; 2014 Jan; 71(1):32-40. PubMed ID: 24217213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
    Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
    Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
    Nicholson LV; Bushby KM; Johnson MA; Gardner-Medwin D; Ginjaar IB
    Neuropediatrics; 1993 Apr; 24(2):93-7. PubMed ID: 8327067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame.
    Nicholson LV; Bushby KM; Johnson MA; den Dunnen JT; Ginjaar IB; van Ommen GJ
    J Med Genet; 1992 Dec; 29(12):892-6. PubMed ID: 1479604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions in the 5' region of dystrophin and resulting phenotypes.
    Muntoni F; Gobbi P; Sewry C; Sherratt T; Taylor J; Sandhu SK; Abbs S; Roberts R; Hodgson SV; Bobrow M
    J Med Genet; 1994 Nov; 31(11):843-7. PubMed ID: 7853367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
    Simard LR; Gingras F; Delvoye N; Vanasse M; Melançon SB; Labuda D
    Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro.
    Ehrenpreis J; Hillers M; Junkes B; Pfordt M; Schwinger E; Vosberg HP
    Genomics; 1991 Jul; 10(3):551-7. PubMed ID: 1889805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion status and intellectual impairment in Duchenne muscular dystrophy.
    Bushby KM; Appleton R; Anderson LV; Welch JL; Kelly P; Gardner-Medwin D
    Dev Med Child Neurol; 1995 Mar; 37(3):260-9. PubMed ID: 7890131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene.
    Gillard EF; Chamberlain JS; Murphy EG; Duff CL; Smith B; Burghes AH; Thompson MW; Sutherland J; Oss I; Bodrug SE
    Am J Hum Genet; 1989 Oct; 45(4):507-20. PubMed ID: 2491010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular deletion patterns in Turkish Duchenne and Becker muscular dystrophy patients.
    Dinçer P; Topaloğlu H; Ayter S; Ozgüç M; Taşdemir HA; Renda Y
    Brain Dev; 1996; 18(2):91-4. PubMed ID: 8733896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy.
    Nicholson LV
    Neuromuscul Disord; 1993; 3(5-6):525-31. PubMed ID: 8186705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin in frameshift deletion patients with Becker muscular dystrophy.
    Gangopadhyay SB; Sherratt TG; Heckmatt JZ; Dubowitz V; Miller G; Shokeir M; Ray PN; Strong PN; Worton RG
    Am J Hum Genet; 1992 Sep; 51(3):562-70. PubMed ID: 1496988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene.
    Bittner RE; Shorny S; Ferlings R; Sperl W; Kress W; Müller CR; Cremer M; Léger JJ; Voit T
    Neuromuscul Disord; 1995 Mar; 5(2):81-92. PubMed ID: 7767097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].
    Takeshima Y; Matsuo M
    Nihon Rinsho; 1997 Dec; 55(12):3120-5. PubMed ID: 9436421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
    Shomrat R; Gluck E; Legum C; Shiloh Y
    Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.
    Winnard AV; Mendell JR; Prior TW; Florence J; Burghes AH
    Am J Hum Genet; 1995 Jan; 56(1):158-66. PubMed ID: 7825572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.